Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Yan J et al. | 2010 | intact cell/cell culture, human mesenchymal stem cells | magnetic field, low frequency, 50/60 Hz | 20 mT |
Lee HM et al. | 2010 | intact cell/cell culture, human intervertebral disc cells | magnetic field, signals/pulses, 50/60 Hz, co-exposure | 1.8 mT |
Mannerling AC et al. | 2010 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, low frequency, 50/60 Hz | 0.025–0.1 mT |
Ruiz-Gomez MJ et al. | 2010 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>)/wild type (WS8105-1C) and <i>rad52 hdf1</i> mutants (<i>rad52</i>, <i>hdf1</i>, <i>rad52 hdf1</i>; radiation sensitive 52, high affinity DNA binding factor 1) | magnetic field, 50/60 Hz | 2.45 mT |
Marcantonio P et al. | 2010 | intact cell/cell culture, BE(2)C cells (human neuroblastoma cells) | magnetic field, low frequency, 50/60 Hz, co-exposure | 1 mT |
Patruno A et al. | 2010 | intact cell/cell culture, HaCaT cells (human keratinocytes) | magnetic field, low frequency, 50/60 Hz, electrotherapy | 1 mT |
Salerno S et al. | 2009 | intact cell/cell culture, human t-lymphocytes | magnetic field, static magnetic field, 50/60 Hz, DC | 0.5 mT |
Koh EK et al. | 2008 | intact cell/cell culture, different human prostate carcinoma cell lines (DU145, LNCaP, PC3) | magnetic field, 50/60 Hz, power transmission line | 0.2–2.5 mT |
Ruiz-Gomez MJ et al. | 2008 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>)/WS8105-1C | magnetic field, 50/60 Hz | 2.45 mT |
Delle Monache S et al. | 2008 | intact cell/cell culture, human vein endothelial cells (HUVEC) | magnetic field, low frequency, 50/60 Hz | 1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.